BR112014012430A2 - métodos para a preparação e isolamento de sais de vardenafila e para a preparação de vardenafila, e, uso de sais de vardenafila com ácidos - Google Patents
métodos para a preparação e isolamento de sais de vardenafila e para a preparação de vardenafila, e, uso de sais de vardenafila com ácidosInfo
- Publication number
- BR112014012430A2 BR112014012430A2 BR112014012430A BR112014012430A BR112014012430A2 BR 112014012430 A2 BR112014012430 A2 BR 112014012430A2 BR 112014012430 A BR112014012430 A BR 112014012430A BR 112014012430 A BR112014012430 A BR 112014012430A BR 112014012430 A2 BR112014012430 A2 BR 112014012430A2
- Authority
- BR
- Brazil
- Prior art keywords
- vardenafil
- preparation
- salts
- isolation
- acids
- Prior art date
Links
- SECKRCOLJRRGGV-UHFFFAOYSA-N Vardenafil Chemical class CCCC1=NC(C)=C(C(N=2)=O)N1NC=2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(CC)CC1 SECKRCOLJRRGGV-UHFFFAOYSA-N 0.000 title 3
- 238000002360 preparation method Methods 0.000 title 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960002381 vardenafil Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20110767A CZ2011767A3 (cs) | 2011-11-24 | 2011-11-24 | Zpusob prípravy a izolace solí vardenafilu s kyselinami |
| PCT/CZ2012/000120 WO2013075680A1 (en) | 2011-11-24 | 2012-11-26 | A method for the preparation and isolation of salts of vardenafil with acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014012430A2 true BR112014012430A2 (pt) | 2017-06-06 |
Family
ID=47435673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014012430A BR112014012430A2 (pt) | 2011-11-24 | 2012-11-26 | métodos para a preparação e isolamento de sais de vardenafila e para a preparação de vardenafila, e, uso de sais de vardenafila com ácidos |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN103946225B (enExample) |
| BR (1) | BR112014012430A2 (enExample) |
| CZ (1) | CZ2011767A3 (enExample) |
| HU (1) | HUP1400334A3 (enExample) |
| IL (1) | IL232652A (enExample) |
| IN (1) | IN2014KN01308A (enExample) |
| WO (1) | WO2013075680A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160317542A1 (en) | 2013-12-09 | 2016-11-03 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
| PL223869B1 (pl) | 2013-12-16 | 2016-11-30 | Starogardzkie Zakłady Farm Polpharma Spółka Akcyjna | Sposób otrzymywania wardenafilu i jego soli |
| CN107445964A (zh) * | 2017-07-29 | 2017-12-08 | 合肥创新医药技术有限公司 | 一种盐酸伐地那非杂质的合成方法 |
| MX2020005890A (es) | 2017-12-20 | 2020-10-19 | Klaria Pharma Holding Ab | Formulacion de pelicula que comprende vardenafil, metodo para su preparacion y uso de la misma. |
| BR112021009958A2 (pt) * | 2018-11-28 | 2021-08-17 | Topadur Pharma Ag | modo duplo de ação de ativadores de guanilato ciclase solúveis e inibidores de fosfodiesterase e seus usos |
| CN114085225A (zh) * | 2021-06-04 | 2022-02-25 | 广东西捷药业有限公司 | 一种伐地那非类似物及其合成方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2395558C (en) * | 1997-11-12 | 2007-07-17 | Bayer Aktiengesellschaft | Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| DE10063108A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen |
| DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| DE102004023069A1 (de) | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
| US7977478B2 (en) | 2006-03-13 | 2011-07-12 | Dr. Reddy's Laboratories Limited | Polymorphic forms of vardenafil |
| DE102007027067A1 (de) | 2007-06-12 | 2008-12-18 | Ratiopharm Gmbh | Verfahren zur Herstellung eines Arzneimittels enthaltend Vardenafil Hydrochlorid Trihydrat |
| CN101965348B (zh) | 2007-09-06 | 2013-11-13 | 上海特化医药科技有限公司 | 伐地那非的制备方法及其中间体 |
| PL2228370T3 (pl) | 2007-12-28 | 2012-10-31 | Topharman Shanghai Co Ltd | N-{1-[3-(2-etoksy-5-(4-etylopiperazynylo)benzenosulfonylo)-4,5-dihydro-5-okso-1,2,4-triazyn-6-yl]etylo}butyroamid, sposób jego wytwarzania i zastosowanie |
| DE102009020888A1 (de) | 2009-05-12 | 2010-11-18 | Ratiopharm Gmbh | Schmelztablette, enthaltend ein Vardenafil-Salz |
| PL390079A1 (pl) * | 2009-12-30 | 2011-07-04 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób otrzymywania wardenafilu i jego izolacji jako soli z kwasem cytrynowym oraz krystaliczna postać tej soli |
| CN101870698B (zh) * | 2010-04-02 | 2012-10-17 | 漆又毛 | 磺酰苯基咪唑并三嗪衍生物及制备方法 |
-
2011
- 2011-11-24 CZ CZ20110767A patent/CZ2011767A3/cs not_active IP Right Cessation
-
2012
- 2012-11-26 HU HU1400334A patent/HUP1400334A3/hu unknown
- 2012-11-26 BR BR112014012430A patent/BR112014012430A2/pt not_active Application Discontinuation
- 2012-11-26 IN IN1308KON2014 patent/IN2014KN01308A/en unknown
- 2012-11-26 WO PCT/CZ2012/000120 patent/WO2013075680A1/en not_active Ceased
- 2012-11-26 CN CN201280057517.3A patent/CN103946225B/zh active Active
-
2014
- 2014-05-15 IL IL232652A patent/IL232652A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ303877B6 (cs) | 2013-06-05 |
| CN103946225B (zh) | 2016-06-15 |
| IN2014KN01308A (enExample) | 2015-10-16 |
| CN103946225A (zh) | 2014-07-23 |
| WO2013075680A1 (en) | 2013-05-30 |
| IL232652A (en) | 2017-05-29 |
| CZ2011767A3 (cs) | 2013-06-05 |
| HUP1400334A2 (hu) | 2014-10-28 |
| HUP1400334A3 (en) | 2014-12-29 |
| IL232652A0 (en) | 2014-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013022869A2 (pt) | cápsula de entrega de bebida e métodos para uso e produção | |
| BR112013033758A2 (pt) | recipiente, uso, dialisador ou unidade de preparação além de método para fabricação de um concentrado | |
| DK2793965T3 (da) | Vævsprodukter med flydeevne | |
| BR112014000260A2 (pt) | composto, e, uso de um composto | |
| BR112014000236A2 (pt) | lipossomas com razão n:p útil para a liberação de moléculas de rna, composição e uso de ditos lipossomas | |
| CR20130677A (es) | FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7 | |
| PT4403579T (pt) | Formulação para anticorpos anti-alfa4beta7 | |
| BR112014001346A2 (pt) | composto nanotransportador, método, composto farmacêutico e uso de um composto | |
| PT2760303E (pt) | Artigo gerador de aerossol para uso com um dispositivo gerador de aerossol | |
| BR112015000534A2 (pt) | método para a preparação de 2,4-dihidroxibutirato, microrganismo, organismo e uso | |
| BR112013020611A2 (pt) | método para produção de compostos quelato de aminoácido, compostos quelato de aminoácido e uso de compostos quelato de aminoácido | |
| BR112013006092A2 (pt) | laminado, matéria-prima do laminado, método para preparação de um laminado e uso do laminado | |
| BR112013029206A2 (pt) | composto, e, uso de um composto | |
| CO6920293A2 (es) | Compuestos antibaterianos y método para su uso | |
| BR112014001418A2 (pt) | compostos, processo para a preparação dos compostos, e, uso dos compostos | |
| BR112014033063A2 (pt) | receptáculo, sistema fornecido com um receptáculo e uma cafeteira, uso de um receptáculo, e, método para fabricar um receptáculo. | |
| PT2758373T (pt) | Processos para a preparação de brometo de n-etil-2-metilpiridínio e brometo de n-etil-metilpiridínio | |
| BR112014014232A2 (pt) | composto e método para a preparação de um composto | |
| BR112013034055A2 (pt) | alcaftadina para uso no tratamento de urticária | |
| BR112013007819A2 (pt) | método para a preparação de um concentrado de glifosato aquoso | |
| BR112014008088A2 (pt) | método para detectar anticorpos, uso de um método, e, kit | |
| BR112013024413A2 (pt) | compostos e métodos para a preparação de diarilpropanos | |
| BR112014005406A2 (pt) | composição de vacina e respectivo uso | |
| BR112013032690A2 (pt) | método para produzir um composto, composto, e, uso do mesmo | |
| BR112013028894A2 (pt) | composto de tiazol, métodos para preparação e uso do mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |